Rare diseases
Investigational molecules
Locations
Back to Lithuania61 clinical trials in Klaipeda, Lithuania. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in LithuaniaKlinikiniai-Tyrimai.lt(opens in a new tab)Study of LY4268989 adipic acid in adults with moderately to severely active ulcerative colitis
LithuaniaLong‑Term Safety and Efficacy of SPY001-001, SPY002 and SPY003 in Adults with Ulcerative Colitis
LithuaniaA Study of Long-acting Antibodies SPY001-001 and SPY002 Alone and Combined for Adults with Moderate to Severe Ulcerative Colitis
LithuaniaStudy of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease
LithuaniaStudy of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
LithuaniaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
LithuaniaPhase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
LithuaniaA study to evaluate the effectiveness and safety of remibrutinib in patients with secondary progressive multiple sclerosis
LithuaniaComparison of REGN7508 versus apixaban and enoxaparin to prevent blood clots in adults after knee replacement surgery
LithuaniaSafety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder
LithuaniaAssessment of NBI-1065845 as an Additional Treatment for Adults with Major Depressive Disorder
LithuaniaStudy on Ferric Derisomaltose for Patients with Iron Deficiency and Chronic Heart Failure
LithuaniaThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on systemic sclerosis, psoriatic arthritis, and ulcerative colitis. Studies are evaluating novel therapies including efgartigimod and sonelokimab to improve patient outcomes.
These trials aim to develop more effective treatments for chronic inflammatory conditions affecting multiple body systems.
Groundbreaking studies in multiple sclerosis treatment, particularly focusing on relapsing-remitting forms. Research includes comparative studies of new biologics and established treatments.
Clinical trials are exploring innovative approaches to improve neurological function and quality of life.
Studies targeting heart failure and atherosclerotic cardiovascular disease, with emphasis on preventing major adverse cardiac events and improving heart function.
Research focuses on both preventive measures and treatment of established cardiovascular conditions.
Advanced research in prostate cancer and bladder cancer, evaluating new treatment approaches including targeted therapies and hormone treatments.
Trials aim to improve survival rates and quality of life for cancer patients.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
